These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9595230)
1. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus. Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S Dis Esophagus; 1998 Jan; 11(1):35-9. PubMed ID: 9595230 [TBL] [Abstract][Full Text] [Related]
2. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus. Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S Dis Esophagus; 2017 Nov; 11(1):35-39. PubMed ID: 29040480 [TBL] [Abstract][Full Text] [Related]
3. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978 [TBL] [Abstract][Full Text] [Related]
4. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer. Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326 [TBL] [Abstract][Full Text] [Related]
5. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer. Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061 [TBL] [Abstract][Full Text] [Related]
6. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]. Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038 [TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy. Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861 [TBL] [Abstract][Full Text] [Related]
8. Serum level of cytokeratin 19 fragment (CYFRA 21-1) indicates tumour stage and prognosis of squamous cell carcinoma of the oesophagus. Tsuchiya Y; Onda M; Miyashita M; Sasajima K Med Oncol; 1999 Apr; 16(1):31-7. PubMed ID: 10382940 [TBL] [Abstract][Full Text] [Related]
9. Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma. Lee JK; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):775-8. PubMed ID: 11510737 [TBL] [Abstract][Full Text] [Related]
10. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062 [TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Kulpa J; Wójcik E; Reinfuss M; Kołodziejski L Clin Chem; 2002 Nov; 48(11):1931-7. PubMed ID: 12406978 [TBL] [Abstract][Full Text] [Related]
12. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck. Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma. Quillien V; Raoul JL; Laurent JF; Meunier B; Le Prise E Oncol Rep; 1998; 5(6):1561-5. PubMed ID: 9769406 [TBL] [Abstract][Full Text] [Related]
14. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA). Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221 [TBL] [Abstract][Full Text] [Related]
15. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Kulpa J; Wójcik E; Radkowski A; Kolodziejski L; Stasik Z Anticancer Res; 2000; 20(6D):5035-40. PubMed ID: 11326663 [TBL] [Abstract][Full Text] [Related]
16. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815 [TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma. Washino S; Hirai M; Matsuzaki A; Kobayashi Y Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857 [TBL] [Abstract][Full Text] [Related]
18. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544 [TBL] [Abstract][Full Text] [Related]
19. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Kawaguchi H; Ohno S; Miyazaki M; Hashimoto K; Egashira A; Saeki H; Watanabe M; Sugimachi K Cancer; 2000 Oct; 89(7):1413-7. PubMed ID: 11013352 [TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 serum analysis in patients with esophageal cancer. Brockmann JG; St Nottberg H; Glodny B; Heinecke A; Senninger NJ Clin Cancer Res; 2000 Nov; 6(11):4249-52. PubMed ID: 11106239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]